NC
AZN icon

Nicholas Company’s AstraZeneca AZN Stock Holding History

Nicholas Company’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.8M Buy
410,378
+140
+0% +$26.3K 1.42% 18
2026
Q1 		$80.9M Sell
410,238
-131,689
-24% -$25.4M 1.59% 11
2025
Q4 		$99.6M Sell
541,927
-22,075
-4% -$3.87M 1.75% 7
2025
Q3 		$86.5M Sell
564,002
-5,798
-1% -$878K 1.47% 9
2025
Q2 		$79.6M Sell
569,800
-10,705
-2% -$1.5M 1.33% 13
2025
Q1 		$85.3M Hold
580,505
– – 1.48% 12
2024
Q4 		$76.1M Buy
580,505
+85,600
+17% +$12M 1.23% 20
2024
Q3 		$77.1M Sell
494,905
-2,908
-0.6% -$469K 1.25% 24
2024
Q2 		$77.6M Hold
497,813
– – 1.29% 13
2024
Q1 		$67.5M Buy
497,813
+84,000
+20% +$11.1M 1.11% 30
2023
Q4 		$55.7M Buy
413,813
+353,608
+587% +$46M 0.99% 41
2023
Q3 		$8.15M Sell
60,205
-263
-0.4% -$35.9K 0.16% 123
2023
Q2 		$8.66M Hold
60,468
– – 0.17% 123
2023
Q1 		$8.39M Buy
60,468
+33
+0.1% +$4.44K 0.17% 131
2022
Q4 		$8.19M Buy
60,435
+2,500
+4% +$314K 0.18% 134
2022
Q3 		$6.35M Buy
57,935
+22,670
+64% +$2.88M 0.15% 156
2022
Q2 		$4.66M Hold
35,265
– – 0.1% 207
2022
Q1 		$4.68M Buy
+35,265
New +$4.23M 0.08% 215

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nicholas Company's AZN Position: Q2 2026 in Review

Nicholas Company increased its AstraZeneca (AZN) stake by 0.03% in Q2 2026, buying an estimated $26.3K and bringing the position to 410,378 shares worth $77.8M. The position accounts for 1.42% of the portfolio, ranked #18.

Nicholas Company first reported a position in AZN in Q1 2022 and has held it in 18 quarters since. The position peaked at $99.6M in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Nicholas Company held 410,378 shares of AstraZeneca worth $77.8M as of Q2 2026.
  • Nicholas Company bought 140 AstraZeneca shares in Q2 2026, an estimated $26.3K.
  • AstraZeneca made up 1.42% of Nicholas Company's portfolio in Q2 2026, its #18 holding.
  • Nicholas Company first reported a position in AstraZeneca in Q1 2022 and has held it in 18 quarters since.
  • Nicholas Company's AstraZeneca position peaked at $99.6M in Q4 2025.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Nicholas Company's 13F filing for Q2 2026, filed 5 Aug 2026.